More articles from 05.01 - Airway pharmacology and treatment

The differential synergistic injurious effect of resistive breathing on pulmonary and extra-pulmonary lung injury
D Toumpanakis, K Glynos, V Vassilakopoulou, A Chatzianastasiou, E Mizi, M Dettoraki, F Perlikos, C Magkou, A Papapetropoulos, T Vassilakopoulos

European Respiratory Journal Sep 2022, 60 (suppl 66) 3507; DOI: 10.1183/13993003.congress-2022.3507
Extrafine triple therapy shows improved efficacy compared to ICS/LABA in a mouse model of asthma
D Miglietta, A R Pisano, A Allen, D Fragni, G Federico, F Bignami, E Zambelli, R Zecchi, F Boscaro, B Pioselli, V Mileo, M Civelli, G Villetti

European Respiratory Journal Sep 2022, 60 (suppl 66) 3021; DOI: 10.1183/13993003.congress-2022.3021
In vitro and ex-vivo evaluation of anti-inflammatory and anti-fibrotic effects of NXP002 in rat and human cells and lung tissue
S Cruwys, M Saunders, A Riddell, B Humphries

European Respiratory Journal Sep 2022, 60 (suppl 66) 2952; DOI: 10.1183/13993003.congress-2022.2952
Comorbidities in severe and non-severe asthma: a nationwide population-based observational study
H Kankaanranta, A Viinanen, P Ilmarinen, J Mehtälä, T Ylisaukko-Oja, J J Idänpään-Heikkilä, L Lehtimäki

European Respiratory Journal Sep 2022, 60 (suppl 66) 2966; DOI: 10.1183/13993003.congress-2022.2966
Antimicrobial properties of Gallium Protoporphyrin in COPD
J Baker, A Baba-Dikwa, S Lea, D Singh

European Respiratory Journal Sep 2022, 60 (suppl 66) 2876; DOI: 10.1183/13993003.congress-2022.2876
Rescue medication use in patients with chronic obstructive pulmonary disease receiving umeclidinium/vilanterol versus tiotropium bromide/olodaterol in England
G Requena, A Czira, V Banks, R Wood, T Tritton, C Castillo, J Yeap, R Wild, C Compton, M Duarte, K Rothnie, A Ismaila

European Respiratory Journal Sep 2022, 60 (suppl 66) 2991; DOI: 10.1183/13993003.congress-2022.2991
Characterization of a Colombian cohort of high-risk phenotypes of COPD according to GesEPOC 2021
C A Celis Preciado, O M García Morales, A Cañas Arboleda, F P Rodriguez Torres, J L Galindo Pedraza, J P Alzate Granados

European Respiratory Journal Sep 2022, 60 (suppl 66) 2973; DOI: 10.1183/13993003.congress-2022.2973
A 7-year retrospective evaluation of lung function in COPD patients pre and post pneumococcal vaccination. Results from RETRIEVE study.
E Papadopoulou, M Bertoli, A Ginis, S Tryfon

European Respiratory Journal Sep 2022, 60 (suppl 66) 2917; DOI: 10.1183/13993003.congress-2022.2917
Biomarker-defined clusters by level of Type 2 inflammatory involvement in severe asthma
D Price, S Burkill, E Wang, M E. Wechsler, E Denton, T N.Tran, N Martin, R Katial, P Barker, J Maspero, M Hew, G Bruselle, G C Christoff, M Sadatsafavi, C A. Torres-Duque, C M. Porsbjerg, C Ulrik, S Hansen, A Altraja, A Bourdin, N G. Papadopoulos, K Kostikas, S Salvi, R W Costello, P Francesca, T Iwanga, C Kook Rhee, M Al-Ahmad, D Larenas Linnemann, J A Fonseca, B G.Cosio, M Koh Siyue, B Kirenga, C Sheu, M Tsai, B Mahboub, J Busby, L G Heaney, P E Pfeffer, P Patel, F Hoyte, Y Liu, C Goh, J Lyu, T Uthaman, W Henley, W Henley

European Respiratory Journal Sep 2022, 60 (suppl 66) 2814; DOI: 10.1183/13993003.congress-2022.2814
Exogenous HSP70 regulates the expression of glucocorticoid receptor in a cell type-specific manner
L Zhou, L Fang, M Tamm, M Roth, D Stolz

European Respiratory Journal Sep 2022, 60 (suppl 66) 2528; DOI: 10.1183/13993003.congress-2022.2528

Main menu

User menu

Search

More articles from 05.01 - Airway pharmacology and treatment

Pages

Contact us